• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种利用大鼠髂内侧淋巴结细胞制备产生大鼠单克隆抗体杂交瘤的新方法。

A novel method of preparing rat-monoclonal antibody-producing hybridomas by using rat medial iliac lymph node cells.

作者信息

Kishiro Y, Kagawa M, Naito I, Sado Y

机构信息

Division of Immunology, Shigei Medical Research Institute, Okayama, Japan.

出版信息

Cell Struct Funct. 1995 Apr;20(2):151-6. doi: 10.1247/csf.20.151.

DOI:10.1247/csf.20.151
PMID:7641297
Abstract

A novel method of preparing hybridomas producing rat monoclonal antibodies was established. The enlarged medial iliac lymph nodes from rats injected via hind footpads with an emulsion of antigen and Freund's adjuvant were used for cell fusion. Ovalbumin was used as a representative antigen. The incidence of hybridomas producing antibody of interest with this method was about 10 times higher than that of hybridomas with the conventional method using mouse or rat spleen cells. The average percentages of hybridomas producing IgG1, IgG2a, IgG2b and IgG2c were 37.1%, 47.0%, 15.9% and 0.0%, respectively. A single injection with antigen was sufficient for immunization in this method.

摘要

建立了一种制备产生大鼠单克隆抗体的杂交瘤的新方法。将通过后足垫注射抗原与弗氏佐剂乳剂的大鼠的肿大的髂内侧淋巴结用于细胞融合。卵清蛋白用作代表性抗原。用这种方法产生感兴趣抗体的杂交瘤的发生率比使用小鼠或大鼠脾细胞的传统方法产生的杂交瘤高约10倍。产生IgG1、IgG2a、IgG2b和IgG2c的杂交瘤的平均百分比分别为37.1%、47.0%、15.9%和0.0%。在这种方法中,单次注射抗原就足以进行免疫。

相似文献

1
A novel method of preparing rat-monoclonal antibody-producing hybridomas by using rat medial iliac lymph node cells.一种利用大鼠髂内侧淋巴结细胞制备产生大鼠单克隆抗体杂交瘤的新方法。
Cell Struct Funct. 1995 Apr;20(2):151-6. doi: 10.1247/csf.20.151.
2
Lymphocytes from enlarged iliac lymph nodes as fusion partners for the production of monoclonal antibodies after a single tail base immunization attempt.单次尾基部免疫尝试后,取自肿大髂淋巴结的淋巴细胞作为产生单克隆抗体的融合伙伴。
Acta Histochem Cytochem. 2006 Jul 1;39(3):89-94. doi: 10.1267/ahc.06001. Epub 2006 Apr 26.
3
A novel method for production of monoclonal antibodies. Evaluation and expectation of the rat lymph node method in cell and molecular biology.一种生产单克隆抗体的新方法。大鼠淋巴结法在细胞与分子生物学中的评估与展望。
Cell Biol Int. 1996 Jan;20(1):7-14. doi: 10.1006/cbir.1996.0003.
4
An improved iliac lymph node method for production of monoclonal antibodies.改良的髂淋巴结法制备单克隆抗体。
Dev Growth Differ. 2022 Jan;64(1):38-47. doi: 10.1111/dgd.12766. Epub 2022 Jan 3.
5
Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen.通过大鼠淋巴结法建立识别人类IV型胶原六种不同α链的表位特异性单克隆抗体。
Histochem Cell Biol. 1995 Oct;104(4):267-75. doi: 10.1007/BF01464322.
6
A rat monoclonal antibody against the chromatin remodeling factor CHD5.一种针对染色质重塑因子CHD5的大鼠单克隆抗体。
Hybridoma (Larchmt). 2010 Feb;29(1):63-6. doi: 10.1089/hyb.2009.0069.
7
Rat monoclonal antibody specific for the chromatin remodeling factor, CHD1.针对染色质重塑因子CHD1的大鼠单克隆抗体。
Hybridoma (Larchmt). 2010 Jun;29(3):237-40. doi: 10.1089/hyb.2009.0106.
8
Monoclonal antibody specific for Dhx9/NDHII/RHA.对Dhx9/NDHII/RHA具有特异性的单克隆抗体。
Hybridoma (Larchmt). 2010 Jun;29(3):259-61. doi: 10.1089/hyb.2009.0107.
9
Production and characterization of monoclonal antibodies to mouse germ cells.
Hybridoma (Larchmt). 2010 Feb;29(1):53-7. doi: 10.1089/hyb.2009.0101.
10
The production of polyclonal and monoclonal antibodies in mice using novel immunization methods.使用新型免疫方法在小鼠体内生产多克隆抗体和单克隆抗体。
J Immunol Methods. 1989 Jun 21;120(2):151-7. doi: 10.1016/0022-1759(89)90236-6.

引用本文的文献

1
IgSF11-RAP1 signaling promotes cell migration and invasion of cutaneous melanoma.IgSF11-RAP1信号传导促进皮肤黑色素瘤的细胞迁移和侵袭。
Cell Commun Signal. 2025 Jul 10;23(1):330. doi: 10.1186/s12964-025-02245-5.
2
Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression.连接外的CLDN10与LAT1协同作用并加速肾透明细胞癌进展。
Cell Commun Signal. 2024 Dec 5;22(1):588. doi: 10.1186/s12964-024-01964-5.
3
A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence.
一种通过免疫颗粒状 tau 寡聚体产生的新型单克隆抗体与 423-430 氨基酸序列的 tau 聚集物结合。
Sci Rep. 2024 Jul 26;14(1):16391. doi: 10.1038/s41598-024-65949-7.
4
Antibody production and characterization of the nucleoprotein of sever fever with thrombocytopenia syndrome virus (SFTSV) for effective diagnosis of SFTSV.抗体制备及严重发热伴血小板减少综合征病毒核蛋白特性分析,用于 SFTSV 的有效诊断。
Virol J. 2023 Sep 7;20(1):206. doi: 10.1186/s12985-023-02173-1.
5
Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrence.LRH1 丝氨酸 510 的异常磷酸化可预测肝细胞癌的复发。
Clin Exp Med. 2023 Dec;23(8):4985-4995. doi: 10.1007/s10238-023-01098-x. Epub 2023 Jun 7.
6
SPON1 is an independent prognostic biomarker for ovarian cancer.SPON1 是卵巢癌的独立预后生物标志物。
J Ovarian Res. 2023 May 13;16(1):95. doi: 10.1186/s13048-023-01180-8.
7
EpCAM proteolysis and release of complexed claudin-7 repair and maintain the tight junction barrier.EpCAM蛋白水解及复合紧密连接蛋白7的释放可修复并维持紧密连接屏障。
J Cell Biol. 2023 Jan 2;222(1). doi: 10.1083/jcb.202204079. Epub 2022 Nov 15.
8
Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing.靶向变应性疾病中的肥大细胞:现有疗法和药物再利用。
Cells. 2022 Sep 27;11(19):3031. doi: 10.3390/cells11193031.
9
Cysteamine-Gold Coated Carboxylated Fluorescent Nanoparticle Mediated Point-of-Care Dual-Modality Detection of the H5N1 Pathogenic Virus.半胱胺金包覆羧基荧光纳米粒子介导的 H5N1 致病性病毒即时双模式检测。
Int J Mol Sci. 2022 Jul 19;23(14):7957. doi: 10.3390/ijms23147957.
10
Trim41 is required to regulate chromosome axis protein dynamics and meiosis in male mice.Trim41 对于调节雄性小鼠的染色体轴蛋白动力学和减数分裂是必需的。
PLoS Genet. 2022 Jun 1;18(6):e1010241. doi: 10.1371/journal.pgen.1010241. eCollection 2022 Jun.